Beutel, Goodman & CO Ltd. Gsk PLC Transaction History

Beutel, Goodman & CO Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$42.05 - $47.77 $18,081 - $20,541	-430 Reduced 3.26%	12,775 $556,000
Q1 2022 May 12, 2022	BUY	$40.23 - $47.74 $39,023 - $46,307	970 Added 7.93%	13,205 $575,000
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $39,074 - $45,536	1,005 Added 8.95%	12,235 $539,000
Q2 2021 Aug 13, 2021	BUY	$36.52 - $41.46 $40,172 - $45,606	1,100 Added 10.86%	11,230 $447,000
Q1 2021 May 14, 2021	BUY	$34.27 - $40.01 $305,688 - $356,889	8,920 Added 737.19%	10,130 $361,000
Q4 2020 Feb 05, 2021	BUY	$34.07 - $39.94 $12,946 - $15,177	380 Added 45.78%	1,210 $44,000
Q3 2020 Nov 13, 2020	BUY	$38.11 - $42.99 $31,631 - $35,681	830 New	830 $31,000
Q1 2020 May 14, 2020	SELL	$32.47 - $48.83 $11.5 Million - $17.4 Million	-355,407 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$42.0 - $48.25 $3.16 Million - $3.63 Million	-75,327 Reduced 17.49%	355,407 $16.7 Million
Q3 2019 Oct 31, 2019	BUY	$40.46 - $43.52 $17.4 Million - $18.7 Million	430,734 New	430,734 $14 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Beutel, Goodman & CO Ltd., based on Form 13F filings with the SEC.

Stay updated on Beutel, Goodman & CO Ltd. with notifications on news.